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Abstract: A gluten-free diet (GFD) is the treatment for celiac disease (CD), but due to its 
complexity, dietitian referral is uniformly recommended. We surveyed patients with CD to 
determine if dietitian use is associated with quality of life, symptom severity, or GFD 
adherence. The survey utilized three validated CD-specific instruments: the CD quality of 
life (CD-QOL), CD symptom index (CSI) and CD adherence test (CDAT). Four hundred 
and thirteen patients with biopsy-proven CD were eligible for inclusion. The majority 
(77%) were female and mean BMI was 24.1. Over three-quarters of patients (326, 79%) 
had seen a dietitian, however, 161 (39%) had seen a dietitian only once. Age, sex, and 
education level were not associated with dietitian use; nor was BMI (24.6 vs. 24.0,  
p = 0.45). On multivariate analysis, adjusting for age gender, education, duration of 
disease, and body mass index, dietitian use was not associated with CD-QOL, CSI, or 
CDAT scores. Our survey did not show an association between dietitian use and symptom 
severity, adherence, or quality of life. Delay in diagnosis was associated with poorer 
outcomes. This is a preliminary study with several limitations, and further prospective 
analysis is needed to evaluate the benefits and cost-effectiveness of dietitian-referral in the 
care of celiac disease patients. 
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Celiac disease (CD) is a common multi-system autoimmune disease, affecting approximately 1% of 
people worldwide [1]. Predisposed individuals develop an immune response to gluten, a protein found 
in the cereal grains: wheat, barley and rye. Autoimmune intestinal damage is the cardinal feature of 
CD, and typically involves villous atrophy, crypt hyperplasia, and increased intraepithelial 
lymphocytes [2]. Symptoms may be subclinical, varying from gastrointestinal upset to severe 
malabsorption [3,4]. Skin, nervous system, and multisystem involvement is also recognized. Strict 
avoidance of gluten-containing foods can reverse both enteric and extra-intestinal manifestations  
of the disease.  
CD is unique in that its treatment consists of a dietary intervention: lifelong exclusion of gluten.  
A gluten-free diet (GFD) is highly effective at improving symptoms of CD in the majority of  
patients [5]. Nevertheless, a significant proportion remains symptomatic, and lack of strict adherence 
to GFD is the primary cause [6]. Those patients with celiac disease who follow a GFD frequently have 
persistent villous atrophy which may result from persistent gluten contamination and, in rare cases, can 
predispose patients to serious sequelae including T-cell lymphoma [7].  
Although straightforward in principle, strict avoidance of gluten is challenging in practice.  
Gluten-containing products are ubiquitous and contamination may occur both consciously and 
unintentionally [8]. Poor labeling can make it difficult to determine which foods are gluten free, and 
options may be limited when eating out and traveling [9]. Moreover, a GFD is significantly more 
expensive, and may be deficient in certain nutrients, when compared to a regular diet [10,11]. Given 
the complexity of maintaining a strict GFD, multiple guidelines recommend dietetic referral for 
patients diagnosed with CD [12–15]. Dietitian involvement was recommended in the National 
Institutes of Health (NIH) Consensus Development Conference on celiac disease (2004) [16]. There is 
evidence that when asked to choose among several referral options, patients themselves express a 
preference for dietetic follow-up [17]. Nevertheless, availability of expert dietetic counselors is limited 
and may impact upon patient outcomes [18]. Membership in celiac advocacy groups, and regular 
dietetic follow-up has previously been reported to be correlate with higher rates of GFD  
adherence [19,20]. However there have been no studies that have directly examined the impact of 
dietitian use on celiac disease outcomes in the United States. As such, we sought to determine if 
dietitian use was associated with quality of life, symptom severity, or GFD adherence in patients with 
celiac disease. 
2. Methods 
Approval was obtained from the Institutional Review Board of Columbia University Medical 
Center prior to initiation of the study. 
Adults (≥18 years of age) with celiac disease were recruited to participate in a survey either via 
email or in-person. A link to an online questionnaire, hosted by SurveyMonkey, was distributed by the 
Celiac Disease Center of Columbia University to an email list of patients affiliated with the Center.  
In addition, the questionnaire was administered to attendees at celiac support group conferences in 
Iowa, California, and New York, and patients additionally completed the questionnaire on-paper 
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during an office visit. Data was collected between November 2010 and July 2011. Prior to distribution, 
the questionnaire was administered to a group of ten patients and subsequently modified for clarity.  
The survey consisted of questions on demographics, celiac disease onset, symptoms, and dietitian 
use. It also included three validated celiac disease-specific instruments to assess quality of life, disease 
activity, and GFD adherence respectively [21–23]. Patients were asked how many times they had seen 
a dietitian: never, once, or more than once. Patients were excluded from the analysis if they did not 
have biopsy-proven celiac disease, or omitted the items on gender, age, or dietitian use.  
The celiac disease-specific quality of life instrument (CD-QOL) was used to assess quality  
of life [21]. This validated instrument consists of 20 questions across four clinically relevant subscales 
(celiac disease-related limitations, dysphoria, health concerns, and inadequate treatment), and asks the 
respondent to indicate the frequency of celiac disease-related symptoms over the previous 30 days. The 
questions are graded on a 5-point Likert scale labeled 1 through 5, where 1 = not at all,  
2 = slightly, 3 = moderately, 4 = quite a bit, and 5 = a great deal. The responses were reverse-coded 
and summed, with a higher score (up to a maximum of 100) suggestive of higher quality of life.  
No clear cut-off point has been established to dichotomize CD-QOL scores; hence membership in the 
lowest quartile of CD-QOL was taken to indicate poorer quality of life.  
The Celiac Symptom Index (CSI) was employed to assess celiac disease-specific symptom  
severity [23]. The CSI consists of 16 questions on a 5-point Likert scale; with scores ≤30 and  
≥45 suggestive of clinical remission and ongoing active disease respectively. For the purpose of our 
analysis; a single cutoff of ≥35 (suggestive of ongoing disease) was used to dichotomize patients.  
The Celiac Disease Dietary Adherence Test (CDAT) was used to assess adherence to a GFD [22]. 
This validated 7-question instrument employs a 5-point Likert scale, with additive scores ranging from 
7 to 35, where higher scores indicate worse adherence. For the purposes of dichotomization, scores 
≥13 were taken to be indicative of poor adherence.  
Univariate analysis was used to identify associations between demographics, dietitian use,  
and CD-QOL, CSI, and CDAT. The Chi-square and Fisher exact tests were used to compare 
proportions of categorical variables. The Mann-Whitney U test was used to compare continuous 
variables. Logistic regression was performed to develop a multivariate model identifying variables 
predictive of three outcomes as determined by these validated scores: poor quality of life, high 
symptom activity, and poor adherence. Two-sided p-values <0.05 were considered significant. All 
statistical calculations were performed with SAS 9.2 (Cary, NC, USA). 
3. Results 
3.1. Patient Characteristics 
Of 600 respondents, 413 with biopsy-proven celiac disease were eligible for inclusion (Table 1). 
Roughly equal numbers of patients completed the survey online (47%) versus on paper (49%).  
The majority (77%) of subjects were female, with almost one-quarter over the age of 60 (24%). The 
cohort was highly educated, with 88% having attained a college degree, and 40% having a graduate or 
higher degree.  
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Table 1. Patient characteristics. 
 n (%) 





































Years since diagnosis  
<1 55 (13) 
1–4 149 (36) 
5–10 115 (28) 
>10 93 (23) 
Delay to diagnosis in years  
<1 51 (12) 
1–4 149 (36) 
5–10 115 (28) 
>10 93 (23) 
Mean Body Mass Index 24.1 














3.2. Disease Characteristics 
Regarding CD presentation, almost half of patients (49%) reported atypical symptoms of fatigue, 
anemia or osteoporosis; 40% reported classical diarrhea-predominant symptoms, and 8% reported no 
symptoms. Most patients’ symptoms were either improved (70%) or somewhat improved (13%) with 
GFD. Mean body mass index (BMI) was in the normal-weight range (24.1). The median time since 
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diagnosis was 5–10 years, and the median delay from onset of symptoms to diagnosis was also  
5–10 years.  
3.3. Dietitian Use  
Of the 413 patients in the analysis, 326 (79%) reported having seen a dietitian, but 161 (39%) had 
only seen a dietitian once. One hundred and sixty-four patients (40%) agreed with the statement ―it is 
hard to find a dietitian knowledgeable about GFD‖. One hundred and ninety-one patients (46%) 
reported gaining weight since starting a GFD. Demographic factors, including age, sex, and education 
level, were not associated with dietitian use (Table 2). There was no significant difference in BMI 
between patients who had and had not seen a dietitian (24.0 vs. 25.6, p = 0.45). Patients who had not 
seen a dietitian were more likely to agree with the statement ―health insurance limits my ability to see 
a dietitian‖ (55% vs. 43%; p = 0.04). 
Table 2. Patient characteristics by dietitian use. 
 Not seen n (%) Seen n (%) p 
Total number 87 (100) 326 (100)  
Age ≥60 20 (23)  78 (24) 0.96 
Female gender 72 (83) 247 (76) 0.21 
College educated 75 (86) 289 (89) 0.53 
Symptoms improved on GFD 63 (72) 225 (69)  0.54 
Mean BMI 25.6 24.0 0.45 
3.4. Quality of Life, Disease Activity, and Dietary Adherence 
Dietitian use was not associated with CD-QOL, CDAT, or CSI on univariate analysis (Table 3). 
Multivariate analysis (Table 4) identified two covariates associated with low CD-QOL, indicative of 
poor quality of life: a long delay (>10 years vs. <1 year) from symptom onset to CD diagnosis  
(OR 3.92, 95% CI 1.45–0.63), and underweight vs. normal weight (OR 3.46, 1.12–10.68). Older age 
(>60) and time since diagnosis (>10 years vs. <1 year) were protective for disease activity as measured 
by CSI (OR 0.35, 95% CI 0.17–0.71 and OR 0.34, 95% CI 0.13–0.87 respectively). Dietitian use was 
not associated with CD-QOL, CSI, or CDAT scores on multivariate analysis (see Table 4). 




CD-QOL 75.4 72.6 0.08 
CSI 33.5 33.3 0.62 
CDAT 12.9 12.1 0.11 
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Table 4. Multivariate analysis of factors associated with low celiac disease quality of life 
(CD-QOL), high CD symptom index (CSI), and high CD adherence test (CDAT). 
Covariate 







OR 95% CI 
Seen a dietitian 1.49 0.68–3.24 0.86 0.45–1.63 0.85 0.47–1.55 
Older age (>60) 0.60 0.26–1.37 0.35 0.17–0.71 0.53 0.28–1.01 
Male gender 1.29 0.61–2.72 1.24 0.58–2.64 0.92 0.48–1.77 
College educated 3.65 0.97–13.7 1.33 0.53–3.38 0.74 0.32–1.71 
Time since diagnosis 
1 
0.38 0.13–1.10 0.34 0.13–0.87 0.48 0.20–1.13 
Delayed diagnosis 
1
  3.92 1.45–10.63 2.08 0.98–4.41 1.05 0.53–2.07 
Underweight vs. normal 3.46 1.12–10.68 2.52 0.79–8.04 1.90 0.66–5.51 
Overweight vs. normal 1.31 0.62–2.75 0.60 0.31–1.16 0.66 0.36–1.21 
Obese vs. normal 0.86 0.33–2.23 0.75 0.32–1.76 0.65 0.29–1.46 
1
 >10 years vs. <1 year. 
4. Discussion 
To our knowledge, this is the first study to examine dietitian use and outcomes as measured by 
validated CD-specific instruments. We were surprised at the lack of association between dietitian use, 
dietary adherence and quality of life. The study has several limitations, including selection bias,  
self-reported outcomes, and poor generalizability, however prior literature addressing these issues is 
similarly limited. While our findings are preliminary, they should provide impetus to further study the 
role of dietary counseling in CD management.  
Several studies have examined dietitian use in CD, with frequently divergent results.  
Ukkola et al. [24] surveyed 698 newly diagnosed CD patients on their perceptions of living with CD, 
and found no correlation between dietitian follow-up and patients’ knowledge of GFD or experience of 
their disease. A similar proportion of patients in this cohort (76%) had received dietitian counseling as 
in our sample (79%). The authors note that despite a lack of correlation, patients often requested more 
detailed dietary counseling when asked to indicate in their own words their wishes/needs, suggesting 
insufficient dietitian contact.  
One outcome measure that has been demonstrated to be associated with dietitian use is improved 
GFD adherence, but this was not seen in our cohort. Wylie et al. [25] concluded in a prospective 
cohort of 99 patients that annual review within the context of a dietitian-led celiac clinic can 
significantly improve adherence as well as other nutritional markers. In a systemic review of  
38 studies examining factors associated with adherence to GFD, Hall et al. [19] also concluded that 
regular dietetic follow-up and annual review in a dietitian-led clinic can improve adherence. 
Membership of a patient support group has been associated with adherence, and studies with cohorts 
recruited from patient support groups trend towards higher adherence rates (66%–90% strict 
adherence) than clinical samples (42%–91%) [26]. There are several possible reasons why these results 
might diverge from that of our study. First, dietitian use was common in our study  
(approaching 80%), leading to a small sample size for patients who had not seen a dietitian, and hence 
decreased ability to detect a difference. Our cohort was very highly educated, with almost 90% of 
patients having a college degree or higher qualification, as compared to a US-wide average of  
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28% [27]. It may be that university-educated patients may have less to gain from dietitian referral: they 
are more health-literate at baseline, and are better equipped to seek out and utilize information from 
other sources in addition to their health professional. As such, the high prevalence of highly educated 
patients in our cohort may have reduced the effect size of dietitian exposure. Hall et al. [19] included 
studies that assessed GFD adherence via a trained nutritionist assessment, which may be more 
sensitive for differences than use of the self-reported CDAT questionnaire. Last, cultural  
factors can influence response to dietary interventions. In a cross-sectional survey from 2004,  
Butterworth et al. [20] noted that South Asian patients with CD were much less likely than Caucasians 
to be members of a support group (53% vs. 80%, p = 0.02), were more frequently dissatisfied with 
dietetic advice (30% vs. 6%, p = 0.01), and exhibited a trend towards poorer dietetic follow-up  
(31% vs. 60%, p = NS). Dietetic follow-up correlated with GFD compliance for Caucasians but not for 
South Asians in that study. It is unclear to what extent these cultural issues apply to our cohort. 
Although dietitian use was common in this study, almost half of these patients had only seen a 
dietitian once, possibly at diagnosis, falling short of CD treatment guidelines. Guidelines published by 
several authorities generally recommend annual dietitian review. The American Gastroenterological 
Association position statement on diagnosis and management of CD advises consultation with an 
experienced dietitian at initiation of a treatment plan and ongoing evaluation at regular intervals by a 
health care team including a dietitian [12]. Several other organizations also publish guidelines 
recommending ongoing dietitian involvement, including the NIH, the United States Department of 
Health and Human Services Agency for Healthcare Research and Quality, the National Institute for 
Health and Clinical Excellence in the United Kingdom, and the World Gastroenterology  
Association [14,16,28,29]. Given a median time since diagnosis of 5–10 years in this cohort, dietitian 
involvement fell well short of recommendations in a significant proportion of patients and insufficient 
dietitian follow-up may have contributed to the lack of effect on outcomes. 
A long delay of >10 years from symptom onset to diagnosis of CD was associated with poor quality 
of life in this cohort. Prior studies have addressed the influence of delayed diagnosis on CD outcomes. 
In a survey of over 1000 patients with CD from Sweden, the mean delay to diagnosis from first 
symptoms was 9.7 years, and 5.8 years from the first doctor visit [30]. A long delay was associated 
with lower quality-adjusted life year scores prior to treatment; however delay in diagnosis had no 
effect on scores following initiation of GFD. The study concluded that untreated CD resulted in poor 
quality of life, which returned to baseline with treatment. Our findings of persistent quality of life 
impairment even following initiation of GFD are novel and warrant further study.  
The limitations of this study include recruitment from a tertiary referral center (the Celiac Disease 
Center of Columbia University) and support groups, leading to a cohort that is likely to have greater 
health literacy than average. The sample size for patients who had not seen a dietitian was low, 
limiting our power to detect a difference in CD outcomes. The actual response rate of the survey is 
unable to be determined as the survey link may have been electronically forwarded by subjects to other 
members of support groups or known contacts with celiac disease. In addition we did not have 
information on the quality, nor expertise and practice setting of the dietitians used by the respondents. 




In this survey of patients with celiac disease, more than 20% of respondents had never seen  
a dietitian, and 39% only saw a dietitian once. Dietitian follow-up fell short of published guidelines, 
which may relate to insurance access issues. Dietitian exposure was not associated with symptom 
severity, adherence, or quality of life, while delay in diagnosis was associated with poorer quality of 
life. Further prospective analysis is needed to evaluate the benefits and cost-effectiveness of dietitian 
referral in the care of patients with celiac disease. 
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